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a b s t r a c t
A detailed experimental analysis of the phase transition thermodynamics of (S)-naproxen and (RS)-
naproxen is reported. Vapor pressures were determined experimentally via the transpiration method.
Sublimation enthalpies were obtained from the vapor pressures and from independent TGA measure-
ments. Thermodynamics of fusion which have been well-studied in the literature were systematically
remeasured by DSC. Both sublimation and fusion enthalpies were adjusted to one reference temperature,
T ¼ 298 K, using measured heat capacities of the solid and the melt phase by DSC. Average values from
the measurements and from literature data were suggested for the sublimation and fusion enthalpies. In
order to prove consistency of the proposed values the vaporization enthalpies obtained by combination
of both were compared to vaporization enthalpies obtained by the group-additivity method and the
correlation-gas chromatography method. The importance of reliable and precise phase transition data for
thermochemical calculations such as the prediction of solid/liquid phase behaviour of chiral compounds
is highlighted.
© 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.
Introduction
The production of pure enantiomers is important for the food
and drug industry and increasingly for the agrochemical sector. It
has been reported that about 56% of the marked drugs are chiral.1
Crystallization processes have been reported to be especially efﬁ-
cient for large-scale enantioseparation.2 Solubilities play an
important role for process design as they deﬁne feasibility and
productivity of a crystallization process. Naproxen as well as about
90%-95% of the chiral systems3 can form a stoichiometric 1:1 mo-
lecular racemic compound, (RS)-naproxen (see Fig. 1, left).
The eutectic composition, xeu, deﬁnes the boundary between
the areas where pure enantiomer or the racemic compound can be
crystallized from solution (indicated as gray area in Fig. 1, left).
Hence, for process design of such systems, the solubility of the
enantiomers, x(S) and x(R), and of the molecular compound, x(RS), as
well as the eutectic composition in solution are characteristic in-
formation. In earlier investigations, we studied solubility behavior
and crystallization-based enantioseparation on several substances,
for example, propranolol hydrochloride,4 3-chloromandelic acid,5
and guaifenesin6 on an experimental basis. However, especially
in early stages of process design, the available amount of
substance is often scarce for detailed experimental studies. Solu-
bility prediction can support and complement experimental
examinations.
To access solubility by computational methods, the free energy
change of the solution process, Dsolcr G
+
sol, has to be split up into
accessible quantities by a thermodynamic cycle. The solution pro-
cess can be thermodynamically described by either transferring the
molecule from the solid crystal via (1) the subcooled melt or (2) the
gas phase into the solution (illustrated in Fig. 1, right).7 The 2
thermodynamic cycles have been compared in a previous study8
for chiral lactide where experimental melting properties and
sublimation enthalpies are used to calculate solubilities and to
estimate the eutectic composition in a solvent mixture. For a
merely predictive method, besides solvent interaction-based
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